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Abstract
Parkinson’s disease is a neurodegenerative disorder that impairs motor and speech
skills due to the degeneration of dopamine-producing cells located in the substantia nigra
portion of the brain. Currently, a novel treatment involves replacing the lost cells with
cultivated stems cells that are capable of producing dopamine. Previous studies
involving this treatment have complications due to the death of the majority of the
injected progenitor cells. It is currently unknown if cell death occurs during delivery or
after injection. A neural catheter has been designed that is capable of taking cytometric
fluorescence-based measurements using a fiber optic probe. This device will allow
researchers to quantify the number of viable cells delivered.
In this study, the original prototype was redesigned in order to be suited for
animal testing. A significant reduction of the original cost resulted from fabrication of
the new design. A static fixture was built and tested using fluorescent microspheres that
used the same optic fiber layout as the catheter to ensure the integrity of the
measurements.
In order to deliver a uniform distribution of cells, cell suspension materials are
required. Several suspension materials were tested to determine which would provide the
most uniform distribution of cells in the medium. The 3RT rat gliomal cell line was used
as a model for neural cell delivery. A well-plate experiment was designed to determine
which cell suspension materials supported cell viability. A separate cuvette experiment
determined the extent of cell settling issues upon delivery. Both experiments tested two
different coating mechanisms; comparing the efficiency of Bovine Serum Album and
PolyHEMA coatings in preventing cell coagulation upon the walls.
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4. Introduction
Parkinson’s disease is a neurodegenerative disorder which afflicts more than 1
million Americans at a cost of $25 billion dollars annually [1]. This chronic and
progressive disease is caused by the degeneration of dopamine producing neurons in the
substantia nigra, which reduces the production of the neurotransmitter dopamine and the
number of connections between nerve cells [2]. Dopamine is essential for the
transmission of nerve impulses to muscles. The degeneration of these neurons reduces
the ability of the basal ganglia to smooth out muscle movements, causing the classic
symptoms of Parkinson’s disease: muscle rigidity, a resting tremor, slowness of voluntary
movements, and a gradual decline of motor skills [2].
The treatment of this disorder is complicated, due to the fact that dopamine is
unable to cross the brain blood barrier. An option that has emerged in recent years is stem
cell therapy. Dopamine-producing stem cells can be injected into the substantia nigra to
supplement production of dopamine by the deficient neurons. However, the prospects of
stem cell therapy in the treatment of Parkinson’s disease are debated. Past studies have
showed that the up to 90 % of the injected cells undergo apoptosis [3-6]. It is currently
unknown if the cell death is due to complications from the injection process or as a result
of an immune reaction. In order to determine the viability of the cells upon insertion, a
cytometric neural catheter has been designed [7]. This device will allow researchers to
quantify the number of viable cells delivered.

5. Problem Statement

.

The original prototype of the neural catheter had key issues that needed to be
addressed by the team, the most significant of which was that it was not biocompatible
due to material selection. In order to enable the device to be used for future animal
testing, the catheter needed to be redesigned to incorporate biocompatible materials. The
original design cost $1600.00 for the fabrication of two prototypes. An additional goal
was to be able to fabricate 4-6 prototypes under a $1600.00 budget. This required a
significant reduction in price per prototype, so the design needed to be rugged but elegant
enough that available machine shops would be able to fabricate the catheter under budget
and to needed specification.
The cytometric neural catheter uses fiber optic elements incorporated into the tip
to quantify the cells and determine viability upon delivery. Past experimentation of the
prototype proved to have cell settling issues which caused nonuniform delivery, possibly
resulting in cell death. The choice of cell suspension material, which lacked the ability to
consistently suspend the cells over time, was theorized to be the root of the settling
problem. One separate project goal was to research and choose a cell suspension material
which would allow a uniform delivery. This required significant testing of different
materials to check for cell viability and cell settling. Experiments that tested these issues
needed to be designed and executed by the team using the researched potential
suspension materials.
This paper discusses the design and calibration of the redesigned catheter. The
methodology and results for determining the most efficient suspension material is also
presented. Several cell suspension materials were tested in order to determine which best

serves the interests of cell delivery. The two factors that were considered were the ability
of the material to support the cells physiologically and to provide uniform delivery.

A. Fall Timeline
Table 1 represents the time allocation for the different aspects of the fall project.

Table 1: Gant Chart for Fall 2008

B. Spring Timeline
Table 2 represents the time allocation for the different aspects of the spring project.

Table 2: Gant Chart for Spring 2009

6. Previous Work
The original catheter prototype was a modular tip designed to be compatible with
existing neurosurgical catheters. The tip incorporates optical fibers for the cytometric
determination of the number of viable cells exiting the port of the tip. The prototype was

fabricated out of common brass and has an outer diameter of 3.2 mm and the exit port is
0.38 mm in diameter. The total length of the catheter tip was 12.8 mm. The tip had the
optical fiber mount as well as a thin-walled extension. The extension served to attach a
multi-lumen tube to the tip which had two cuts in it. One of the cuts would protect the
optical fibers upon insertion and delivery and the other would serve to connect to the
mount. The schematic of the multi-lumen tube is shown in Appendix 2. The delivery
tube would be inserted inside of the multi-lumen tube. The original pocket for the
porthole was cut with a mill saw. A rendered image of the original base is shown in
Figure 1. The schematic of the original prototype is in the Appendix 3 [7].

Figure 1: Rendered Image of the Original Base

The tip has a series of smooth grooves, designed to assist in the placement of the
optical fibers. These grooves allow the self-alignment of five optical fibers. Two fibers
were polished at a 45° angle and were coated with a 100 nanometer layer of chromium
using electron beam evaporation in order to create a reflective surface. The fibers were
spaced 0.25 mm apart and attached using an ultraviolet light curing epoxy [7]. The setup of the optical fibers is shown in Figure 2.

Figure 2: Set-up of Fiber Optic Assembly

As shown in Figure 2, the blue fibers act as the light delivery and collection fibers.
The two 45° polished fibers act as turning mirrors, allowing the excitation beam to enter
the system by the delivery fiber and exit via the collection fiber. The alignment grooves
allow the illumination delivery and the turning fibers to work together so that the
excitation beam, designed for fluorescence illumination, can be delivered across the exit
port. The green fiber, as shown in Figure 2, serves to measures the scatter of the
excitation beam and the fluorescence within the cell suspension [7].
The original experimentation used the RT2 rat gliomal cell line as a neural cell
delivery model. The delivery suspension material was Phosphate Buffer Saline (PBS).
These cells were transfected to express green fluorescent protein (GFP) and are
designated as 3RT1 cells [8]. As the cells die the expression of GFP halts or dramatically
decreases [7]. The catheter tip delivers an excitation beam designed to fluoresce GFP.
The optical fiber set-up measures the fluorescence of the delivery, allowing the

quantification of cell death due to GFP expression. Dr. Boyd Evans, III of Oak Ridge
National Laboratory has applied for a patent for this device.

7. Catheter Design
One of the original goals of the project was to design and fabricate a rugged
version of the neural catheter tip that could be used in animal testing. In order to
accomplish this goal, our team had many issues to address. There were physical and
material requirements that needed to be taken into consideration in the design process.
The design also needed to allow the fabrication of 4-6 prototypes under a $1600.00
budget, so a significant reduction in cost was required. Design modifications were made
in order to reduce the complication of the original design and lower the fabrication cost.

A. Design
The physical requirements of the design required precisely cut v-edges, all cut to
the same depth and angle, which would house six optical fibers. These v-edges needed to
be the same height as the optic fibers in order to create a flush surface. A port hole would
be cut at the top of the catheter tip and needed to line up precisely with the middle v-edge
to ensure accurate cytometric measurements. This port hole also had to reach the inlet
hole for delivery. The optical fibers would need to be protected during insertion and
delivery, so the new design had to encompass this as well. The maximum size allowed
for the design was a 1/8” diameter with a 1/2” length, to be allowed for future animal
testing. The assembly of the testing apparatus needed to be taken into account, so the
design was modified to ensure ease of assembly.

Several initial designs were proposed and drafted (Appendix 1), but many of them
did not solve all the initial requirements. Eventually, it was decided that the elimination
of the extension and the multi-lumen tube would significantly reduce the cost of
fabrication and also ease the assembly of the full testing apparatus. The thin-wall
extension on the previous design was a difficult and costly cut. This extension served to
attach the expensive multi-lumen tube, which would protect the fibers. The use of the
multi-lumen tube enhanced the complication of the design, due to the fact the tip had to
be designed with intense restrictions so that the multi-lumen tube would attach to the
catheter tip (Appendix 2). It was decided that a bridge material could serve as an
extension, which would allow the attachment of the delivery tubing. A cheap and
biocompatible heat-shrink tube would surround the tip and the optical fibers in order to
serve as protection against the natural environment. This significantly reduced the
fabrication cost and also reduced the size of the assembly. The schematic of the
redesigned catheter tip is shown in Figure 2. The full-rendered image of the redesigned
tip is shown in Figure 3.

Figure 2: Final Design of Catheter Tip

Figure 3 – Full Body Render of Assembly Base

The v-edges that run along the catheter tip were designed to be the same height as
the optic fibers and needed to be straight cuts. To ensure the cuts were the same height
and depth, the machine shop that fabricated the catheters needed to have a mill saw. As
shown in Figure 2, the v-edges were given slight fillet cuts to smooth out the shape cut.
This would allow the fibers to sink into the v-edge, ensuring they did not extend above
the catheter.
The inlet hole on the catheter for the bridge tube connection was designed to have
a 1/16” diameter. This connection between the catheter tip and the bridge connector was
designed to be push-fit so that an adhesive between the bridge tube connection and the
catheter would not be required. This push-fit design was done to lower the difficulty
when building the full assembly. Another benefit to using a 1/16” diameter between the
inlet hole and bridge connection was that stock items could be readily purchased instead
of the need for custom tubing. The schematic of the bridge tubing is shown in Appendix
4. The inlet hole was offset from the v-edges equal to the diameter of the fibers to allow
ease of assembly and to avoid a potential bending of the fibers. A separate supply tube
that would connect to the other end of the bridge tubing was also designed to be push-fit.
Luer locks were purchased to allow attachment of the supply tube to the syringe pump.
The bottom of the catheter tip was given a flat edge in order to increase stability while
attaching the optic fibers to the v-edges.
The porthole was designed to sit in a pocket that would be cut into the top of the
catheter. The pocket was cut to the same depth as the v-edges and would ensure that all
the cells would be counted as they passed through the tip and exited out the porthole. As
shown in Figure 2, the porthole was designed to be cut as far back as possible into the

bevel of the inlet cut. This would serve to prevent the cells from coagulating at the end
of the inlet hole. These design modifications were done to help ensure accurate counting
of cells.
Tolerances were important for this device. It was important that the v-edges were
of near exact same depth and width to ensure the laser light would travel in the correct
path. Due to the small scale of the device, tolerances were designed to be as small as
possible. A render of the full catheter assembly, including catheter tip, bridge connection
tube, supply tube, and fiber optics, can be seen in Figure 4.

.
Figure 4 – Full Assembly Render: Titanium Catheter, PEEK Bridge Connector Tubing (black), PVC
Supply Tube (Red), Fiber Optics (yellow)

B. Material Selection
Material selection was an important aspect of the design. There were many
requirements that the selected material had to meet, among these were: inherent
biocompatibility, MRI compatibility, machinability, and ease of sterilization. Through

much research, it was decided that titanium would prove to be the best base material for
the catheter tip.
The most important requirement is that the material was inherently biocompatible.
Stem cell treatment was estimated to last between two hours and two weeks [7], so it was
important to select a material which could remain in vivo for that amount of time without
causing negative side effects. Titanium has been shown to be able to remain in vivo for
up to 26 weeks without causing behavioral changes or neurological deficits [9]. It is also
important to note that titanium does not require surface treatment for biocompatibility, so
this choice also reduced costs.
Magnetic resonance imaging (MRI) compatibility was also important. The
placement of the catheter in the correct region of the brain, the substantia nigra, is
required for effective treatment. The material must be able to undergo an MRI scan to
determine the correct placement of the device. Titanium is a nonferrous metal, so there is
not a magnetic attraction in the MRI environment, allowing the metal to undergo an MRI
scan [10]. Also, there is not a significant heat increase in titanium during an MRI, so
there would not be any damage to local tissues during the scan [11].
Another important thing to note is the creation of artifacts during an MRI.
Titanium is MRI compatible due to the fact that it is not ferromagnetic, but it is slightly
paramagnetic, causing the image to read a slight artifact on the scan. Through research, it
was determined that the artifact would not interfere in the determination of placement of
the catheter tip [12, 13].
Titanium was also chosen due to ease of machining. The smooth and precise
v-edge tolerances were essential to the design and a material was needed that could be

machined to the design’s strict tolerances. The design required a specific tool for
machining the v-edges, a mill saw, and would leave a clean, finished surface after the
cuts were made. Shular Tools, located in Oak Ridge, Tennessee, had the tools and ability
to manufacture the device.
Polyether-ether-ketone (PEEK), a thermoplastic, was chosen as the material for
the bridge tubing (Appendix 4). There were several requirements of the bridge tubing
that PEEK fulfilled. The material had to be rigid to allow ease of insertion and also had
to be inherently biocompatible. It also needed to be manufactured in thin wall tubes to
ensure steady flow from the transition of the bridge tubing to the catheter tip. PEEK is
mass produced as thin-wall tubing in a stock size that fit our design. This choice of
material fit all of the requirements of the bridge tubing and was significantly cheaper than
custom tubing or any other alternative.
The delivery tube is a polyvinylchloride (PVC) tube. This tubing was designed to
be push-fit as well, easing assembly by fitting to the PEEK connector tube without any
need of an adhesive. The heat-shrink tubing was polyolefin. Both of these materials are
biocompatible and sold in stock sizes that fit our design. The titanium tip and the optical
fibers are able to undergo a low-dose gamma radiation [14, 15]. The polyimide covering
of the optical fiber has an aromatic group attached to polymer chain, making it resistant
to low-dose radiation [15]. PEEK must undergo Ethylene Oxide (EtO) sterilization [16].
The PVC tubing and polyolefin heat shrink tubing will be disposed of after use.

C. Cost Analysis of Design
The new design simplified the original design and made it more efficient. The
tips were manufactured out of titanium while utilizing a PEEK bridge connector to fulfill
the application requirements. Six prototypes of the tips were fabricated for only $408.00.
The PEEK tubing cost $26.50 for 25 feet and fifteen feet of PVC and 6 feet of the heat
shrink tubing totaled $7.50. These items gave a total cost for the design of $442.00 which
was only a fourth of the catheter budget. The design of catheter is both rugged and ready
for animal testing and is significantly cheaper than the previous prototype.

8. Fabrication of Static and Catheter Fixtures
Two different testing fixtures were made: static fixtures and catheter assemblies.
In order to assemble the fixtures, polished optical fibers were required since a clean
signal was a necessity for testing. The fibers were polished at 90˚ and 45˚ angles using
the Bare Fiber Adapter Kit by Ocean Optics™ and designed hockey-pucks, which are
shown in Figure 5.

Figure 5: Hockey-puck

Each fiber was polished using three successive sandings: 15 µm, 5µm, and 1 µm
and viewed using the Clauss Fiber Optic Inspection Microscope™ to determine if the
fiber was clear. The 45˚ fibers and the middle fiber were coated with a 100 nanometer
layer of chromium using electron beam evaporation in order to create a reflective surface.
The 45˚ fibers were chromed to act as turning mirrors and the middle fiber was chromed
to enhance the signal. The light delivery fiber was lined up with the laser in order to pass
the light to the fixture to excite the microbeads or 3RT1 cells. The collection fiber was
attached to a computer that collected data using the Ocean Optics OOIbase32 program.

A. Static Fixture
The static fixtures were assembled on the back of a Petri dish. The fibers were
assembled in accordance to the original catheter fiber optic set-up. The fibers were
assembled manually on the Petri dish using a video microscope. The video microscope
was also used to confirm the quality of the fibers angles. The fibers were adhered to the
Petri dish using a Dura Hold Blocking Compound (Part # KL16050) and cured using an
ELC-410 Spot Cure System™.
Due to sensitivity and accuracy required for the alignment of the fibers, the
assembly of the static fixtures was time consuming. The alignment of the fibers had to be
perfect, along with the appropriate rotation of the 45˚ fibers. The first static fixture took
two weeks to assemble with the last two fixtures taking a week a piece to assemble. A
highly magnified image of the static fixture is shown in Figure 6.

Figure 6: Static Fixture Under Video Microscope

B. Catheter Assembly
The two catheter assemblies proved much less time consuming than the static
fixtures. The smooth design of the v-edges allowed easy insertion and rotation of the
optical fibers, drastically cutting down time of assembly. The catheter set-ups took a day
each to assemble. These fibers were also adhered to the fixture using a Dura Hold
Blocking Compound (Part # KL16050) and cured using an ELC-410 Spot Cure System™.

9. Calibration Experiment
The static fixture was made in order to test and calibrate the fiber-optic layout of
the titanium catheter. Microbeads of increasing concentration would be placed on the
static fixture and fluoresced. Ideally, a linear relationship between the fluorescent
intensity and fluorescent concentration should be obtained, proving that the optic-fiber
set-up is able to successfully measure the concentration of microbeads.

A. Methods
The used microbeads were 10 µm in diameter, approximately the same size as
neurons. The beads were originally stored in a solution that contained 0.15M NaCl, .05%
Tween 20, and 0.02% thimerosal. In order to simulate the environment the beads were
stored in, the experimental solutions that were made contained 99.5 mL of water and 0.5
mL of Triton X 100, which imitated the detergent Tween 20. Before the solutions were
made, the beads were vortexed and sonicated to suspend the beads and ensure even
distribution. Seven solutions were made with increasing concentration of fluorospheres
including a blank solution, 10%, 30%, 50%, 70%, 85%, and 100% microbeads. Each
concentration was made in 5 mL volumes with 5 µL placed upon the static test fixture to
take readings. The laser was set at 477 nm and powered at 4.8 mW. The experiment was
run using green fluorescing microbeads, which fluoresced at 515 nm.

B. Results
Figure 7 is an image of the static fixture during experimentation. The microbeads
were placed on the static fixture and fluoresced.

Figure 7: Static Fixture with Green Fluorescing Microbeads

The results of calibration experiments are shown in Figures 8 and 9. Figure 8 is
the data obtained from the Ocean Optics OOIbase32 program, showing the intensity
curve of each of the concentrations. Figure 9 displays the relationship between the
intensity at 537.93 nm and the concentration.

Figure 8: Fluorescent Intensity versus Wavelength

Figure 9: Fluorescent Intensity at 537.93 nm versus Concentration

C. Discussion
Figure 8 shows the fluorescent intensity versus the wavelength. The peak shown
at 477 nm is the intensity measured directly from the laser. The highest fluorescence of
the green beads is shown at 537.93 nm. It can be seen here that as the concentration
increases that the fluorescing intensity does as well.
As hypothesized, a linear relationship was obtained between the fluorescing
intensity at the fluorescing wavelength of the microbeads and the concentration (Figure
9). This shows that as the concentration of the microbeads increases, the measured
intensity increases as well. Statistical analysis was done to prove linearity; an R2 value of
0.9655 was obtained. This relationship shows that the fiber optic layout of the titanium
catheter can accurately measure fluorescing intensity.

10. Cell Suspension - Reasons
An extensive literature review for suitable media was accomplished in the fall of
2008. From the literature six media were determined to be candidates for testing in the
spring of 2009. The six media chosen were phosphate buffer saline (PBS), Dulbecco’s
modified eagle medium (DMEM) without phenol red, varying concentrations of methyl
cellulose, N-isopropyl acrylamide (NIPPAM), NIPPAM –co-Acrylic Acid (NIPPAM-coAAc), and NIPPAM-co-AAc with fibronectin proteins functionalized to the copolymer
for cell adhesion. It was determined that the best media to test were PBS, DMEM, and
methyl cellulose on a basis of availability, expense, and ease of processing. The
synthesis of the polymeric media was more expensive and difficult to synthesize. Also, a
stock pile of polymer would be small and the synthesis of the polymer would take more
than a day as compared to the hour it took to make the PBS/methyl cellulose gels.
These original media were first used to determine their efficacy in suspending the
cells in the first cuvette experiment. However, from the data received in the first cuvette
experiment the cells had died within two hours of the experiment. Because of the cellular
death the choices of media were modified as to improve the cell viability for the cuvette
experiment and, ultimately, delivering the cells for in vivo studies. Combinations of the
three original media—methyl cellulose, PBS, and DMEM—were made to optimize cell
viability and suspension. Methyl cellulose acted to increase the density of the suspension
material to promote suspension of the cells. DMEM is a cell growth media which
promotes proliferation. It contains all of the essential elements for cell life and has a
greater density than PBS, but not to a significant degree. The compositions involving
DMEM were meant to support cell viability and provide suspension. In addition to these

original media selections artificial cerebrospinal fluid (CSF) was also selected as a
possible option.
PBS was the media used in the original design for the cell delivery. The density
of the cells was greater than the density of PBS, causing the cells to settle in solution.
Since it was noted the cells settled, PBS was the control media for the new media
selected. The media used for the cuvette experiments was the following: PBS (control),
DMEM only, artificial CSF, 1% methyl cellulose in PBS by weight, 0.5% methyl
cellulose in PBS by weight, 1% methyl cellulose in DMEM by weight, 0.5% methyl
cellulose in DMEM by weight with the intention to find the media that is best suited for
uniform delivery of cells and cell viability.

11. Cell Suspension – Well Plate
A well-plate experiment was designed and executed to determine viability of
3RT1 cells in a variety of suspension materials using different coating methods. After
the wells were coated, cells were added to the suspension materials in each well. The
well-plate was then viewed under an incubated fluorescent microscope, which excited the
3RT1 cells. This fluorescence allowed the visual determination of cell viability in the
given suspension material and coating.

A. Methods
Seven suspensions were tested, including: Phosphate Buffer Saline (PBS), 1%
methyl cellulose in PBS, 0.5% methyl cellulose in PBS, DMEM, 1% methyl cellulose in
DMEM, 0.5% methyl cellulose in DMEM, and Artificial Cerospinal Fluid (CSF). All
DMEM culture media used in the experiments were without phenol red. Each of these

solutions was tested with three different coating methods. One section did not have a
coating and served as a control. The other two coatings were polyHEMA and bovine
serum albumin (BSA). The 3RT1 cells were incubated at 37ºC with 5 % carbon dioxide
buffer and fed with phenol red fortified DMEM with 10 % fetal bovine serum.

Figure 10: Well-plate Set-up

In order to coat the wells, approximately 25 µL of each coating was added to the
corresponding well. After 5 minutes, the BSA was aspirated out of the well. Similarly,
the polyHEMA was removed after 30 minutes. After the coating process, 100 µL of each
suspension material was added to the wells. The 3RT1 cells were then added to each
well in 100 µL amounts to give a 1:1 ratio between the suspension material and cells.
This entire process was performed in a fume hood to prevent contamination.
After the addition of the cells, the well-plate was placed in an incubator for 5
minutes to allow adequate mixing of the cells and suspension material. The well-plate
was then viewed under an incubated Nikon Diaphot 300™ fluorescent microscope and
images were captured using OpenLab™ software on a laptop.
The experiment was performed three times. The first experiment was executed
using the following suspension materials: PBS, 1% methyl cellulose in PBS, 0.5% methyl
cellulose in PBS, and 1% methyl cellulose in DMEM and pure DMEM. In this

experiment, only two coating methods were tested: BSA and no coating. PolyHEMA
was not included in this experiment due to the fact that it was not available for testing at
that time. The second experiment was performed with the same suspension materials, but
included a 0.5% methyl cellulose in DMEM solution. PolyHEMA was added as an
additional coating method in the second experiment. The third experiment had the same
experimental set-up as the second experiment, but added artificial CSF as an additional
suspension material. The well-plate set-up is shown in Figure 10. A similar set-up was
used for all three experiments.

B. Results
Altogether, 180 images were taken of well-plate data with the best images from
each group collected and made into montages shown below. The first experiment results
are shown in Figure 11. The images from top to bottom are PBS, 1% methyl cellulose in
PBS, 0.5% methyl Cellulose in PBS, 1% methyl cellulose in DMEM and finally pure
DMEM. The left column represents the uncoated wells; the right column is the BSA
coated wells.

Figure 11: Experiment 1 Results (Column 1 – No Coating, Column 2 – BSA)/(Row A - PBS, Row B - 1%
Methyl Cellulose in PBS, Row C - 0.5% Methyl Cellulose in PBS, Row D - 1% Methyl cellulose in
DMEM, Row E - 0.5% Methyl Cellulose in DMEM, Row F - pure DMEM)

Figure 12 is the results from well-plate experiment 2. From top to bottom, the
suspension materials are PBS, 1% methyl cellulose in PBS, 0.5% methyl cellulose in PBS,
1% methyl cellulose in DMEM, 0.5% methyl cellulose in DMEM, and pure DMEM. The
far left column is the untreated wells. The middle column is the polyHEMA coating,
while the third column is BSA. In the first column, there is not an image of the 0.5%
methyl cellulose in PBS with no coating. All of the cells had died and there was not a
good representative image of the well available.

Figure 12: Experiment 2 Results (Column 1 – No Coating, Column 2 – PolyHEMA, Column 3 –
BSA)/(Row A - PBS, Row B - 1% Methyl Cellulose in PBS, Row C - 0.5% Methyl Cellulose in PBS, Row
D 1% Methyl cellulose in DMEM, Row E - 0.5% Methyl Cellulose in DMEM, Row F - pure DMEM, Row
G - artificial CSF)

Figure 13 is the results from well-plate experiment 3. From top to bottom, the
suspension materials are PBS, 1% methyl cellulose in PBS, 0.5% Methyl Cellulose in
PBS, 1% Methyl cellulose in DMEM, 0.5% Methyl Cellulose in DMEM, pure DMEM,
and artificial CSF. The far left column is the untreated well. The middle column is the
polyHEMA coating, while the third column is BSA.

Figure 13: Experiment 3 Results Figure 12: Experiment 2 Results (Column 1 – No Coating, Column 2 –
PolyHEMA, Column 3 – BSA)/(Row A - PBS, Row B - 1% Methyl Cellulose in PBS, Row C - 0.5%
Methyl Cellulose in PBS, Row D 1% Methyl cellulose in DMEM, Row E - 0.5% Methyl Cellulose in
DMEM, Row F - pure DMEM, Row G - artificial CSF)

C. Discussion
The results from the first experiment are shown in Figure 11. This was the first
well-plate experiment and the first opportunity to use Nikon Diaphot 300™ to determine
cell viability. The results appear to suggest that each of the solutions support cell

viability similarly, but this is believed to be misleading. Due to a time constraint, the
pictures were taken quickly and did not allow adequate mixing of suspension material
and the cells. Also, due to inexperience with the equipment, there is also a significant
background fluorescence, which misleads the viewer into overestimating the cell viability
in the suspension material. Considering the results of experiment 3, which show a
difference in the cell viability dependant upon the suspension material and coating
method, these results are believed to be misleading due to the aforementioned reasons.
The second run of the experiment also resulted in skewed results (Figure 12).
During testing, multiple users were utilizing Nikon Diaphot 300™. This led to the
incubator being left open during testing and long intervals of time occurred between
measurements. Regardless of the skewed results, it was observed that coatings were
required for viability. The coatings prevent the cells from clinging to the walls, which
causes a reduction in cell viability. This can be seen Figure 12 in the no-coating column.
It was difficult to capture a good image with the wells that lacked a coating, due to the
fact the cells gripped to the well-wall. Also, cell coagulation was observed in the 1%
methyl cellulose in DMEM solution.
By the third experiment, the experimental protocol had been finalized and there
was no outside interference. This experiment yielded the best results, due to the fact all
of the wells were imaged in one setting. These results are shown in Figure 13.
Comparatively, all three coating methods of pure PBS show a limited amount of cell
viability. It was also noted that the cells initially settled very quickly. Increasing
concentrations of methyl cellulose were added to the PBS solutions. It was hypothesized
that higher concentrations of methyl cellulose would reduce cell viability due to

coagulation effects [17]. Experimentally, it was shown that the cells were more viable in
the 1% methyl cellulose than the 0.5% methyl cellulose solutions. The 1% methyl
cellulose solution shows viable and suspended cells. Suspension can be noted due to the
cloud effect in the images. The 0.5% methyl cellulose solutions did not show evidence of
cell viability. This is theorized to be due to experimental procedures. The 1% methyl
cellulose images were captured before the 0.5% solutions. It is believed that that the 1%
solutions were alive due to the fact the images were taken first, but cell death occurred
shortly after imaging. Our hypothesis holds true with the increasing concentrations
methyl cellulose in DMEM. The 1% methyl cellulose in DMEM solution does not
support cell viability. The 0.5% solution keeps the cells viable and also participates in a
limited amount of suspension. As the concentration of methyl cellulose increases, cell
viability decreases due to the coagulation effect [17]. It is also noted that as the
concentration of DMEM increases in these solution, the cell viability also increases. This
is due to the nature of DMEM. This suspension was designed to promote cell growth and
proliferation, increasing the concentration would provide a more suitable environment for
the cells, promoting cell viability.
The pure DMEM solutions had the best cell viability with all coating methods.
The solution also shows evidence of suspension. Artificial CSF also showed cell
viability, although not as significant as DMEM. The BSA coating of Artificial CSF had a
similar viability to the pure DMEM solution. Artificial CSF promoted cell viability, but
settled quickly.
Image capture proved more difficult with the wells that were not coated. Coatings
tended to reduce the amount of cells clinging to the well-plate walls. Overall, the BSA

coating method appeared to be the best choice. This method tended to do the best job in
keeping the cells off of the well-plate walls, easing image capture.
Experimentally, it was determined that cell viability was an issue in the 0.5%
methyl cellulose in PBS and 1% methyl cellulose in DMEM solutions in all three sets.
Results suggested that BSA coatings produced better imaging. In conclusion, it was
determined that the 1% methyl cellulose in PBS, 0.5% methyl cellulose in DMEM, pure
DMEM, and Artificial CSF solutions better promoted cell viability.

12. Cell Suspension - Cuvette
A cuvette experiment was designed in order to test for cell settling in each
solution. Each cuvette was prepared with either a BSA or PolyHEMA coating, a given
concentration of cells, and one of the following suspension materials: PBS, 1% Methyl
Cellulose in PBS, 0.5% methyl Cellulose in PBS, and 1% methyl cellulose in DMEM,
0.5% methyl Cellulose in DMEM, pure DMEM, and artificial CSF. Blanks were also
made of each suspension material and coating method in order to test for background
fluorescence. The cuvettes were placed in CUV – ALL—UV™ four-way cuvette holder
to be excited with a 477 nm laser and the intensity was measured over time. The
experimental set-up can be seen in Figure 14.
A decrease in the intensity over time shows that the cells are settling within the
given suspension material. After all readings had been made, the solution was agitated in
order to resuspend the cells, and an additional reading was taken. This allowed the
determination of whether the decrease in intensity was due to cell settling or cell death.

A. Methods
The coating method of the cuvette experiment was similar to the well-plate
experiment. BSA and PolyHEMA were added to the cuvettes in 1.5 mL volumes. After
5 minutes, the BSA was removed. Similarly, the PolyHEMA was removed after 30
minutes. Fourteen cuvettes of each coating were prepared; 7 of these cuvettes would
receive cells, while the other 7 would serve as blanks. The blanks would serve to check
for background fluorescence of the suspension material and coating. The cell volume to
suspension material ratio was 1:1, each adding 0.75 mL to the final volume of 1.5 mL.
This was done in order to ensure that the ratio was the same as the well-plate experiment.
During testing, the CUV – ALL—UV™ holder was placed on a hot plate in an
enclosed environment in order provide a suitable environment for the cells. The
temperature was monitored throughout experimentation. The cuvette was then excited by
a 477 nm laser, causing the 3RT1 cells to fluoresce at 512 nm. In order to prevent
photobleaching, the laser was only allowed to hit the cuvette for few seconds at each
measurement. This experiment was run three times. The first experiment had inconsistent
and unreliable data. Experimental design modifications were made in order to obtain
reliable data for the next two experiments. For the second experiment, samples that
showed signs of settling had data points taken for 20 minutes while samples that did not
show settling were only measured for 10 minutes. For the third experiment, all samples
were run for the full 20 minutes. For each experiment, a measurement was taken at every
minute for the first 5 minutes, and then every two minutes after that for 20 minutes. The
last measurement of each cuvette was taken after the cells were agitated. This was done
to check to see if the change of intensity was due to cell settling or cell death.

Figure 14: Image of Cuvette Experiment Set-up. Shown: Laser, Cuvette Holder in Incubator, Data Reader

B. Results
As mentioned previously, the first experiment did not yield reliable results. The
results of the second experiment are shown in Figures 15 and 16; the results of the third
experiment are shown in Figure 17 and 18. Figure 15 and 17 are the intensities of given
suspension material with a PolyHEMA coating versus the time. Figure 16 and 18 are the
intensities of given suspension material with a BSA coating versus the time.

Figure 15: Experiment 2 - Suspension Material with PolyHEMA coating: Intensity versus Time

Figure 16: Experiment 2 - Suspension Material with BSA Coating: Intensity versus Time

Figure 17: Experiment 3 - Suspension Material with PolyHEMA coating: Intensity versus Time

Figure 18: Experiment 3 - Suspension Material with BSA coating: Intensity versus Time

C. Discussion
As mentioned previously, the first experiment did not yield reliable results. The
procedure was modified for the next two experiments in order to create a consistent
experimental environment. The cells were given a more suitable environment by

incubating the CUV – ALL—UV™ set-up. Agitation was reduced between testing times
by only testing one sample at a time.
An important aspect of the experiment was to identify the suspension materials
which had background fluorescence. Knowledge of the background fluorescence would
be useful when delivering the cells through the neural catheter. It is important that any
background fluorescence be accounted for during cell excitation during future
experimentation.
For each suspension material and coating, a blank and a cell sample were tested.
In both experiments, solutions with DMEM components had background fluorescence. It
was also noted that the fluorescence intensity of the DMEM solutions were reduced with
the PolyHEMA coating in comparison to the BSA coating. In experiment 3, the
background fluorescence of the DMEM solutions doubled in comparison to experiment 2.
A different, shorter light-delivery fiber was used for experiment 3; this is believed to be
the cause of the increase of fluorescent intensity. The other suspension materials and
coatings had neutral fluorescent intensity, similar to the default intensity of the program.
Pure PBS and DMEM showed significant settling in all cases. One exception is
shown in Figure 16; it is believed that the cells in the PBS solution had died, so there is
no sign of settling. It was also noted that both coating methods, BSA and PolyHEMA,
sufficiently kept the cells from attaching to the walls.
It was theorized that solutions with a higher concentrations of methyl cellulose
would act as better suspension materials, due to the property of the compound. Methyl
cellulose is significantly denser than PBS, promoting cells to remain suspended within
the solution. This hypothesis was supported by experiment 2 and the PolyHEMA coating

of experiment 3. Generally, 1% methyl cellulose solutions in PBS and DMEM
suspended the cells better than the 0.5% methyl cellulose in their respective solutions.
The only deviation in this trend is shown in Figure 4. The cell settling in the 1% methyl
cellulose in PBS solution was not significantly different from 0.5% methyl cellulose in
PBS. In both PBS and DMEM solutions, increased concentration of methyl cellulose
promotes better cell suspension. The only exception is the methyl cellulose in DMEM
solutions with a BSA coating from experiment 2. All concentrations showed similar
settling issues (Figure 16).
Comparing equal concentrations of methyl cellulose, the PBS solutions served as
better cell suspension materials than DMEM. This is hypothesized to be due to the
material properties of the combined solutions. During experimentation, it was noted that
the methyl cellulose and PBS solutions acted more as a gel, while methyl celluloseDMEM solutions acted more fluid-like. Gel-like material, such as the methyl cellulose in
PBS solutions, would better suspend the cells, due to the fact that the cells would have
difficulty moving freely throughout the solution. A fluid-like material, such as methyl
cellulose in DMEM, would allow the cells to settle in solution.
In order to ensure that the decrease of intensity was not due to cell death, the last
data points were agitated. These points were compared to the original intensity. If the
intensity of agitated data points was less than the original intensity, it would suggest that
the cells were dying in solution. In each experiment, the agitated intensity was close to
the original measurement. In some cases, the agitated intensity was greater than the
initial intensity. This suggests that the solutions should initially mixed more thoroughly
in order to provide a reliable range of data.

In general, artificial CSF showed signs of settling. In the second experiment with
BSA coating, the artificial CSF was vortexed before the first two data points were taken
causing a drop in intensity (Figure 16). After seeing this significant drop, the solutions
were no longer vortexed. Overall, the BSA coating of CSF showed a significant amount
of settling; the CSF with PolyHEMA coating only showed slight signs of settling. The
extreme settling of the CSF with BSA coating is believed to be due to the vortexing. In
the third experiment, the BSA coating of CSF showed signs of suspension. The
PolyHEMA coating showed settling after 10 minutes. With this data, it is difficult to
ascertain the degree of settling artificial CSF would undergo, although it does appear that
it would experience some cell settling.
The 1% methyl cellulose in PBS solution appeared to be the best solution to
prevent cell settling. Increasing the amount of methyl cellulose in solution appeared to
decrease the amount of cell settling. The PBS solutions were better cell suspensions than
the equivalent DMEM solutions. The cells settled very quickly in pure PBS and DMEM.
The cell settling effects of artificial CSF were difficult to determine, but it appears that
the cells gradually settle. Coatings were invaluable in reducing the amount of cells on the
cuvette walls.

13. Summary/ Conclusion
All of the goals of this project were successfully completed. The original
prototype of the neural catheter was redesigned, allowing the device to be used in future
animal studies. The fiber optic layout of the catheter tip was shown to effectively count
cells.

As shown in the well-plate experiments, the presence of DMEM in the solutions
promoted cell viability. Pure DMEM appeared to promote cell viability to the greatest
extent. However, 1% methyl cellulose in PBS was also shown to be effective in
promoting cell viability. It was also determined that coatings are required to sustain cell
viability.
The 1% methyl cellulose in PBS provided the most effective suspension material;
this was displayed in the cuvette experiments. It is suggested that 1% methyl cellulose in
PBS would provide the best cell suspension material in terms of viability and effective
suspension. The 1% methyl cellulose in PBS solution showed exceptional cell
suspension properties and was also one of the few solutions able to show cell viability in
the well-plate experiment. Another benefit is that neither material gives off a fluorescent
signal when excited by the laser. This will benefit future experiments by providing a
cleaner signal and easing data analysis.

14. Budget
MABE CAPSTONE DESIGN BUDGET
Mechanical, Aerospace and Biomedical Engineering
Academic Year: 2008/2009 Faculty: Dr. Jack Wasserman
Project Title: Neural Catheter and Cell Suspension Design
Student Names:
Erik Bowman, Brad Meccia, Kaan Serpersu, Jennifer Watson
Project Narrative:
The group was tasked with designing and overseeing the fabrication of a neural catheter
that could eventually be used for animal testing. The requirements for the catheter
included: biocompatible, MRI compatible, fit the current methods of testing, make the

assembly process easier, lower fabrication costs, v-grooves for alignment of fiber optics
to be used in cytometric measurements, less than 1/8 inch diameter, and compatible with
sterilization methods.
The group was also tasked with researching and selecting the best cell suspension
medium to be used in the delivery of 3RT1 cells. The cell suspension needed to be
biocompatible, biodegradable, bioabsorbable, should not allow the cells to settle in the
bottom of the suspension, and should allow the cells to disperse uniformly though the
catheter.
The group has finished the design and has had 6 titanium catheters fabricated. Seven
cells suspensions were chosen and their effect on cell viability and effectiveness of
suspending the cells has been determined.

Budget:
a) Supplies (brief description and usage)
PBS ($35.40), Dulbecco minimal eagle medium ($21.50), Acrylic acid ($79.57),
Isopropylacryamide ($209.57) – All used as potential cell suspensions
Catheter tips (6) - $408, the designed catheter fabricated from Shular Tools
PEEK tubing 25ft ($26.50), PVC 15ft and Heat Shrink tubing 6ft ($7.50), Leur
Locks (12) ($5.00) – All used in final assembly with the catheters. The PEEK
tubing serves as a bridge between the catheter and the PVC tube, with the heat
shrink tubing being used to secure all pieces together. The Leur locks are places at
the opposite end and used to inject the 3RT1 cells through the PVC into the
catheter.
Optical Fiber - $60, attached to the catheter in 6 places, with two being cut at 45
degrees. Will pass a laser through where the strength will be measured by a
computer.
Epoxy adhesive - $31.55, used to attach the optical fibers to the catheters. UV
light source needed to cure.
Polishing Paper - $15, before being attached to the catheters all 6 of the fibers
need to be polished in order for a clear signal to be measured.
Bare Fiber Adapter Kit - $262, this kit was needed in order to hold the fibers in
place for polishing.
Clauss Fiber Optic Inspection Microscope - $239.97, microscope used to check to
see if the fiber was fully polished.

Fluorospheres - $230, before 3RT1 cells are used in testing, these fluorospheres
are used in order to calibrate the testing apparatus.
Total Amount: $1631.56
b) Student Travel
Purpose: To go to ORNL to build and test the catheter assemblies and test cell
suspension materials in Dr. Boyd Evans’s labs
Where: ORNL
When: Fall – Once a week for each member at least
Spring – Every Tuesday, Thursday, and Friday.
How many traveling: On Tuesday and Thursday – 3 students, Friday – 2 students.
Total Amount: $400 for both Fall and Spring
c) Equipment ($1,000 and up purchase; <$1,000 per item goes under Supplies)
Description & Purpose:
ELC-410 Spot Cure System, $935 a UV light source used to cure the UV epoxy.
CUV – ALL—UV, $1047 – Cuvette Holder
Video microscope - $2000, the fibers are about 250 microns in diameters. The
microscope was needed in order to build the apparatuses, check fiber quality, and
check laser route.
Nikon Diaphot 300™ - $7600 Microscope with image capturing capabilities
Total Amount: $11,942.00
d) Software (must be specific)
Ocean optics usp 2000 $199 – used in testing to measure signal strength
Mechanical Desktop 2008 student version, $0.00 – used to design catheter
OpenLab – Image capturing program, came with Nikon Diaphot

Total Amount: $199
e) Others (brief description)
Purpose:
Total Amount: $0.00
TOTAL BUDGET AMOUNT:

$14,172. 56

15.Acknowledgements
We would like to first thank Mr. Haffner of the Haffner foundation who provided
funding for this research. We would also like to thank Dr. Boyd Evans of Oak Ridge
National Labs. Without his guidance none of this would have been possible. Thanks also
go to Dr. Tim McKnight, whose help could not be understated, Dr. George Gillies and
Jerry Brooks whose advice on the design documents was of great help, Dr. April
McMillan, Dr. Helen Fillmore, and Dr. Jack Wasserman who all helped with some aspect
of the project.
16. References
[1] Parkinson’s Disease Foundation. Ten Frequently-Asked Questions about Parkinson’s
Disease. Parkinson’s Disease Foundation. New York, NY. www.pdf.org. 2006. Accessed
March 2, 2009.
[2] Eidelberg, D and Michael Pourfar. “Parkinson’s Disease”. Merck Manual of
Diagnosis and Therapy. 18th ed, sec. 16, chap. 221. Retrieved March 23, 2009, from
http://www.merck.com/mmpe/sec16/ch221/ch221g.html#sec16-ch221-ch221g-75.
[3] CR Freed, PE Greene, RE Breeze, WY Tsai, W DuMouchel, R Kao, S Dillon, H
Winfield, S Culver, JQ Trojanowski, D Eidelberg, S Fahn. Transplantation of embryonic
dopamine neurons for severe Parkinson's disease. N Engl J Med. 344(10):710-9. 2001.
[4] CR Freed, MA Leehey, M Zawada, K Bjugstad, L Thompson, RE Breeze. Do patients
with Parkinson's disease benefit from embryonic dopamine cell transplantation? J Neurol.
250 Suppl 3:III44-6. 2003.
[5] A Bjorklund, SB Dunnett, P Brundin, AJ Stoessl, CR Freed, RE Breeze, M Levivier,
M Peschanski, L Studer, R Barker. Neural transplantation for the treatment of Parkinson's
disease. Lancet Neurol.
2(7):437-45. 2003.
[6] JH Kordower, TB Freeman, BJ Snow, FJ Vingerhoets, EJ Mufson, PR Sanberg, RA
Hauser, DA Smith, GM Nauert, DP Perl, CW Olanow. Neuropathological evidence of
graft survival and striatal reinnervation after the transplantation of fetal mesencephalic
tissue in a patient with Parkinson's disease. N Engl J Med. 332(17):1118-24. 1995.
[7] BM Evans, III, SW Allison, HL Fillmore, WC Broaddus, RL Dyer, GT Gillies.
Cytometric catheter for neurosurgical applications.

[8] HL Fillmore, J Shurm, P Furqueron, SS Prabhu, GT Gillies, WC Broaddus. An in
vivo rat model for visualizing glioma tumor cell invasion using stable persistent
expression of the green fluorescent protein. Cancer Lett. 141(1-2):9-19. 1999.
[9] Mofid M.M, Thompson R.C, Pardo C.A., Manson P.N., Vander Kolk C.A, Persing
J.A. Biocompatibility of fixation materials in the brain. Plastic and reconstructive surgery
100(1): 14-22.
[10] Ritabh Kumar, Richard A. Lerski, Stephen Gandy, Benedict A. Clift, Rami J.
Abboud. Safety of orthopedic implants in magnetic resonance imaging: An experimental
verification. Journal of Orthopaedic Research 24(9): 1799-1802.
[11]R. Buchli, P. Boesiger, D. Meier. 1988. Heating effects of metallic implants by MRI
examinations. Magnetic Resonance in Medicine 7(3): 255-261
[12]Matsuura, Hideki, Takashi Inoue, Hiromu Konno, Makoto Sasaki, Kuniaki
Ogasawara, and Akira Ogawa. “Technical Note: Quantification of susceptibility artifacts
produced on highfield.” J Neurosurg 97:1472–1475, 2002.
[13] Farahani K, Sinha U, Sinha S, et al: Effect of field strength on susceptibility
artifacts in magnetic resonance imaging. Comput Med Imaging Graph 14:409–413, 1990.
[14] Vezeau PJ, GF Koorbusch, RA Draughn, JC Keller, JE Lemons, and JE Lemons.
“Effects of multiple sterilization on surface characteristics and in vitro biologic responses
to titanium.” Journal of oral and maxillofacial surgery 54(6): 738-746. 1996.
[15] Hemmerich, Karl. “Polymer Materials Selection for Radiation-Sterilized Products”.
Medical Device and Diagnostic Industry. Feb 2000: 78.
[16] Kurtz, SM and JN Devine. “PEEK Biomaterials in Trauma, Orthopedic, and Spinal
Implants.” Biomaterials Nov 28(32): 4845-4869. 2007.
[17] Stewart, GJ, Yuqin W, and S. Niewiarowski. “Methylcellulose protects the ability
of anchorage-dependent cells to adhere following isolation and holding in suspension.”
BioTechniques 19(4): 598-604. 1995.

17.Appendix

Appendix 1 – Montage of Initial Designs

Appendix 2 – Schematic of the Multi-Lumen Tube

Appendix 3 – Schematic of Original Design

Appendix 4 – Schematic of the Bridge Tubing
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ASTM F2026 - 08 Standard Specification for Polyetheretherketone (PEEK)
Polymers for Surgical Implant Applications

ASTM F665 - 98(2003) Standard Classification for Vinyl Chloride Plastics Used in
Biomedical Application

ASTM D2851 - 98(2004) Standard Specification for Liquid Optical Adhesive

